Exiger CEO Testifies Before Congress on Pharmaceutical Supply Chain Risks

WASHINGTON, DC. SEPTEMBER 16, 2025 – Exiger CEO Brandon Daniels will testify before the U.S. Senate Special Committee on Aging on September 17, 2025, for the “Prescription for Trouble: Drug Safety, Supply Chains, and the Risk to Aging Americans” hearing.

Daniels has been invited by the committee, led by Chairman Rick Scott and Ranking Member Kirsten Gillibrand, to share what Exiger’s AI and proprietary analysis of U.S. pharmaceutical supply chains reveals about the nation’s dangerous dependence on foreign producers and the risks posed to vulnerable populations, including American seniors.

Leaders from the healthcare industry, academia, regulatory bodies, and advanced technology will testify at the hearing at 3:30PM in the Hart Senate Office Building, SH-216. Live broadcast will be available on https://www.aging.senate.gov/.

“Expert witnesses will testify on the urgent need for stronger Food and Drug Administration oversight, including more rigorous testing and foreign inspection parity, as well as the importance of reshoring the production of essential medications here at home in America,” according to the hearing announcement. “The hearing will also spotlight tragic cases of adverse events linked to substandard generics and highlight solutions to protect the health and safety of aging Americans.”

The hearing follows the release of Exiger’s investigative report, “A Bitter Pill: America’s Dangerous Dependence on China-Made Pharmaceuticals,” earlier this year. The findings of the report are the results of Exiger’s AI-powered risk assessment of 2,300+ companies, including drug manufacturers, packagers, labelers and suppliers, and 1,300+ active pharmaceutical ingredients. Exiger’s analytics revealed patterns of severe quality control issues, including contamination and falsified testing data, deep dependencies on foreign drug manufacturers and unethical international sourcing practices, including forced labor.

About Exiger

Exiger is revolutionizing the way corporations, government agencies and banks navigate risk and compliance in their third-parties, supply chains and customers through its software and tech-enabled solutions. Exiger’s mission is to make the world a safer and more transparent place to succeed. Empowering its 550 customers across the globe, including 150 in the Fortune 500 and over 55 organizations across the Defense Industrial Base and government agencies, with award-winning AI technology, Exiger leads the way in ESG, cyber, financial crime, third-party and supply chain management and recently achieved FedRAMP® Moderate Authorization. Named one of Fast Company’s 2023 and 2024 ‘Brands That Matter’ and recipient of the Third Party Risk Association’s 2024 Innovator Award, Exiger’s work has been recognized by 50+ AI, RegTech and Supply Chain partner awards. Learn more at Exiger.com and follow Exiger on LinkedIn.

For more information, please contact:

Kody Gurfein
Chief Marketing Officer
1.914.393.0398
kgurfein@exiger.com